Panbela Therapeutics ROCE
Qual é o ROCE de Panbela Therapeutics?
O ROCE de Panbela Therapeutics Inc. é -1,359.79%
Qual é a definição de ROCE?
O retorno sobre o capital empregado (ROCE) é um índice financeiro que mede a lucratividade de uma empresa e a eficiência com que seu capital é usado.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de empresas na Setor Health Care em NASDAQ em comparação com Panbela Therapeutics
O que Panbela Therapeutics faz?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas com roce semelhantes a Panbela Therapeutics
- Millennial Precious Metals Corp tem ROCE de -1,485.19%
- Oragenics Inc tem ROCE de -1,468.71%
- Hemp Naturals tem ROCE de -1,452.04%
- Advantagewon Oil tem ROCE de -1,446.04%
- Paringa Resources tem ROCE de -1,393.41%
- Graycliff Exploration tem ROCE de -1,374.81%
- Panbela Therapeutics tem ROCE de -1,359.79%
- U.S. Lithium tem ROCE de -1,313.60%
- Ucommune International Ltd tem ROCE de -1,285.37%
- Kopin tem ROCE de -1,279.14%
- 22nd Century Inc tem ROCE de -1,242.47%
- Imagin Medical Inc tem ROCE de -1,230.40%
- Aravive Inc tem ROCE de -1,217.82%